Related Experiment Videos
Clinical applications of proton therapy
J L Habrand1, P Schlienger, L Schwartz
1Centre de Protonthérapie d'Orsay, France.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique
|January 1, 1996
Summary
Proton therapy is effective for difficult-to-treat tumors near critical structures. It shows high local control for ocular melanomas and good survival rates for skull base and cervical canal sarcomas.
Area of Science:
- Radiation oncology
- Medical physics
- Oncology
Background:
- Proton therapy presents advantages for unresectable, radioresistant tumors near critical structures.
- Over 15,000 patients globally have received proton therapy.
- Established indications include ocular melanomas and sarcomas.
Purpose of the Study:
- To discuss the potential advantages of proton therapy.
- To review current global proton therapy protocols.
- To highlight key treatment outcomes.
Main Methods:
- Review of existing proton therapy protocols.
- Analysis of patient treatment data for specific tumor types.
- Discussion of clinical outcomes and efficacy.
Main Results:
- Proton therapy achieves over 95% local control for ocular melanomas at 5 years.
- Survival rates for skull base and cervical canal sarcomas range from 84-94% at 5 years.
- Demonstrates significant efficacy in challenging tumor sites.
Conclusions:
- Proton therapy is a valuable tool for managing complex tumors.
- Its efficacy is well-established in specific oncological indications.
- Ongoing research and protocol development continue to refine its application.